Hikma Pharmaceuticals PLC HIK
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover HIK, but with our powerful screener, you can find
stocks in the same sector,industry, or style and filter on our unbiased ratings and valuation metrics.
News
Trading Information
- Previous Close Price
- GBX 1,905.00
- Day Range
- GBX 1,893.00–1,921.00
- 52-Week Range
- GBX 1,711.00–2,165.00
- Bid/Ask
- GBX 1,716.00 / GBX 2,000.00
- Market Cap
- GBX 422.47 Bil
- Volume/Avg
- 181,100 / 332,095
Key Statistics
- Price/Earnings (Normalized)
- 10.41
- Price/Sales
- 1.77
- Dividend Yield (Trailing)
- 3.23%
- Dividend Yield (Forward)
- 3.23%
- Total Yield
- 3.23%
Company Profile
Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 9,100
- Website
- https://www.hikma.com
Comparables
Valuation
|
Metric
|
HIK
|
APH
|
MCG
|
|---|---|---|---|
Price/Earnings (Normalized) | 10.41 | 8.89 | 12.10 |
Price/Book Value | 2.34 | 1.11 | 0.43 |
Price/Sales | 1.77 | 1.29 | 0.14 |
Price/Cash Flow | 9.65 | 6.69 | 2.01 |
Price/Earnings
HIK
APH
MCG
Financial Strength
|
Metric
|
HIK
|
APH
|
MCG
|
|---|---|---|---|
Quick Ratio | 0.87 | 1.97 | 0.60 |
Current Ratio | 1.66 | 2.93 | 0.66 |
Interest Coverage | 5.99 | −3.96 | 0.38 |
Quick Ratio
HIK
APH
MCG
Profitability
|
Metric
|
HIK
|
APH
|
MCG
|
|---|---|---|---|
Return on Assets (Normalized) | 10.41% | 5.83% | 1.11% |
Return on Equity (Normalized) | 22.07% | 11.32% | 4.16% |
Return on Invested Capital (Normalized) | 15.49% | 9.14% | 4.35% |
Return on Assets
HIK
APH
MCG
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Fyfdjvxbdp | Pjdb | $86.5 Bil | |||
| Merck KGaA ADR
MKKGY
| Byytgpvl | Mdyglc | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Zkkbmwqv | Nrtvf | $46.6 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Mxhrhzpl | Sgr | $19.9 Bil | |||
| Viatris Inc
VTRS
| Dbqhpjdk | Dxlbw | $13.6 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Zptmlfpdj | Rgr | $13.4 Bil | |||
| Catalent Inc
CTLT
| Ldtxfcyy | Wyttql | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Ytgzcxw | Jxzdlq | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Vmqnxwt | Zywm | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Rylzkvxz | Kqngr | $2.5 Bil |
United States